Regional anesthesia

Effects of Combining Short‐ and Long‐Acting Local Anaesthetics in Peripheral Nerve Blocks—A Systematic Review With Meta‐Analysis and Trial Sequential Analysis

Acta Anaesthesiol ScandPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

Our assessment suggested that combining short and long-acting LA reduced block duration by 2½ h compared with long-acting LA and increased it by 3½ h compared with short-acting LA. The changes in duration of onset time were limited and likely not clinically relevant.

Study context

Population
Adults undergoing peripheral nerve blocks
Participants
1,539 adults · 21 trials
Comparison
Combined short- and long-acting local anaesthetics (LA) vs either a short- or long-acting LA alone
Outcome
Duration of analgesia
Methodological detailstrial sequential analysis, risk of bias-2, Grading Recommendations Assessment, Development and Evaluation (GRADE)
  • Trial sequential analysis
  • Risk of bias-2
  • GRADE

Pooled result

As reported in the abstract

MD, min (95% CI)P value
Combination vs Long-acting LAtau = 181 min, I2 = 96%, TSA-adj. 95% CI: −254 to −71, GRADE = moderate
−162(−246 to −79)
P < 0.01
Combination vs Short-acting LATSA-adj. 95% CI: 150 to 282, GRADE = moderate
216(163–269)
P < 0.01

Further pooled results

OutcomeMD (min) (95% CI)P value
Onset time, combination vs long-acting LA−8.0 (−11.5 to −4.6)P < 0.01
  • Onset time, combination vs long-acting LA: tau = 7.8 min, I2 = 98%; Trial sequential analyses (TSA)-adj. 95% CI: −11.8 to −4.3; GRADE = low

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Effects of Combining Short‐ and Long‐Acting Local Anaesthetics in Peripheral Nerve Blocks—A Systematic Review With Meta‐Analysis and Trial Sequential Analysis. Acta Anaesthesiol Scand. Published 30 October 2025. doi:10.1111/aas.70141

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.